Related Experiment Video
Updated: Sep 18, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
Associations of Type 2 Diabetes with Risk of Overall and Site-Specific Cancers in a Cohort of Predominantly
Pranoti Pradhan1, Wanqing Wen1, Alvin C Powers2
1Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Background:
The prevalence of type 2 diabetes (T2D) is higher in Black than in White Americans, and individuals with T2D have an increased cancer risk. We investigated the association of T2D with the risk of all cancers combined and 21 site-specific cancers among predominantly low-income participants who experienced a disproportionately high risk of both T2D and cancer.
Methods:
The study included 76,121 participants (mean age, 52.0 years; 67.2% Black) from the Southern Community Cohort Study. T2D was ascertained at the baseline survey. Incident cancer was ascertained via linkage to state cancer registries. Cox proportional hazards models were used to estimate the associations between T2D and cancer after adjusting for confounders.
Results:
Among participants, 21.2% (N = 16,137) had baseline T2D, and 9.7% (N = 7,376) were diagnosed with incident cancer. Compared with individuals without T2D, individuals with T2D had a significantly elevated risk of all cancers combined (HR, 1.07; 95% confidence interval, 1.01-1.13) and several site-specific cancers, including cancers of the stomach, colorectum, pancreas, liver/intrahepatic bile duct, kidney, and renal pelvis as well as leukemia. The significant association for most cancers was largely observed within 15 years after T2D diagnosis, except for cancer of the pancreas and liver/intrahepatic bile duct, for which elevated risks remain statistically significant 15 to 30 years after T2D diagnosis.
Conclusions:
T2D was associated with the risk of overall and certain site-specific cancers in this predominant low-income population.
Impact:
Preventive measures to reduce the burden from T2D could help reduce the risk of overall cancer and several site-specific cancers.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...